Foundations Investment Advisors LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 96.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,160 shares of the medical equipment provider's stock after buying an additional 570 shares during the quarter. Foundations Investment Advisors LLC's holdings in Intuitive Surgical were worth $605,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. raised its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter valued at $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical during the third quarter valued at $38,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
Insider Buying and Selling at Intuitive Surgical
In other news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,843 shares of company stock valued at $15,357,560. Company insiders own 0.90% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on ISRG. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research note on Thursday, October 17th. UBS Group boosted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday. Truist Financial boosted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday, December 5th. Finally, Evercore ISI boosted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $613.10.
Get Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Price Performance
NASDAQ ISRG traded down $0.80 during trading on Friday, reaching $579.39. 646,683 shares of the company's stock traded hands, compared to its average volume of 1,946,994. The firm has a market cap of $206.37 billion, a price-to-earnings ratio of 90.45, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39. The company's 50 day simple moving average is $549.92 and its two-hundred day simple moving average is $508.00. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.